CAR-T Clinical Trials
17 recruitingBiologic
Phase 16Phase 25Not Applicable4Phase 32Early Phase 11
Showing 1–17 of 17 trials
Recruiting
Phase 2
CAR-T in Relapsed/Refractory Multiple Myeloma
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Dr. Zaineb Akram10 enrolled2 locationsNCT07689058
Recruiting
Phase 1
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
Diffuse Large B-Cell Lymphoma (DLBCL)Large B-cell LymphomaNon-Hodgkin Lymphoma (NHL)+2 more
Abramson Cancer Center at Penn Medicine14 enrolled1 locationNCT07478848
Recruiting
Phase 3
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center130 enrolled5 locationsNCT07223021
Recruiting
Phase 1Phase 2
Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT07169500
Recruiting
Phase 3
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
B-ALLMRD-positiveAllogenetic Hematopoietic Stem Cell Transplantation
Peking University People's Hospital70 enrolled1 locationNCT07441291
Recruiting
Phase 1Phase 2
Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors
Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Shenzhen University General Hospital20 enrolled1 locationNCT07399769
Recruiting
Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study
Large B-cell Lymphoma
Fudan University80 enrolled1 locationNCT07236203
Recruiting
Not Applicable
Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors
Solid Tumors
Guangzhou Bio-gene Technology Co., Ltd20 enrolled1 locationNCT07152236
Recruiting
Not Applicable
Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer
Colorectal Cancer (CRC)
Guangzhou Bio-gene Technology Co., Ltd20 enrolled1 locationNCT07152210
Recruiting
Not Applicable
Clinical Study on the Safety and Efficacy of CD19-BCMA CAR-T Cell Therapy for Connective Tissue Diseases
Connective Tissue Diseases
Guangzhou Bio-gene Technology Co., Ltd20 enrolled1 locationNCT07152223
Recruiting
Phase 1
To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL
CD7 Positive R/R PTCL
Peking University People's Hospital18 enrolled1 locationNCT07143929
Recruiting
Not Applicable
CD-19 CAR-T Cell for Pediatric ALL or Lymphoma
Lymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric
Hong Kong Children's Hospital18 enrolled1 locationNCT06866873
Recruiting
Early Phase 1
A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression
Gliomas
JIANG LONGWEI3 enrolled1 locationNCT06828341
Recruiting
Phase 2
Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL
CART TherapyB-NHL
Ruijin Hospital144 enrolled1 locationNCT06695013
Recruiting
Phase 1
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
Multiple MyelomaB-cell LymphomaHematological Malignancy
The Third Affiliated Hospital of Southern Medical University60 enrolled1 locationNCT06758713
Recruiting
Phase 2
Obinutuzumab, Zanubrutinib, and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell Lymphoma
Mantle Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China39 enrolled2 locationsNCT06504199
Recruiting
Phase 1
CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
T-ALLT-lymphoblastic Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.9 enrolled1 locationNCT06136364